Moreover, TBRG4’s consistent pro-tumorigenic role across osteosarcoma, pancreatic cancer, HCC, and now LUAD suggests it is a conserved oncogenic factor, warranting broader oncology research, and further validates the robustness of BREGI as a functionally coherent gene set. Here, TBRG4 is linked to pancreatic neoplasm.